Skip to main content

Closed

CRDF: Cardiff Oncology, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-9033.9%

ROIC-134.1%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage0.0×

Current ratio3.27×

Cardiff Oncology, Inc.

CRDFNASDAQ·USD·Closed

Cardiff Oncology, Inc.

CRDFNASDAQ·USD·Closed

$0.86

+0.52%

$0.86

+$0.00 (0.52%)

52W Range

4thpctl

Volume

0.37×avg

Mkt Cap

56.14MUSD

P/E

-1.3TTM

Div Yield

–ann

52W Range

4thpctl

Volume

0.37×avg

Market Cap

56.14MUSD

P/E Ratio

-1.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings